LAP3 and cranioectodermal dysplasia: In line with this, research on duodenal biopsies from active CeD, GFD-managed CeD, and healthy volunteers showed that enterocytes of healthy individuals and GFD-managed, but not active CeD patients, can fully digest certain digestion-resistant gliadin peptides (6), suggesting defects in BBM peptidase activity in active CeD.